PureTech Health plc
PRTC
$17.26
$0.120.70%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -67.07% | -67.07% | -84.88% | -84.88% | 11.78% |
| Total Depreciation and Amortization | -40.74% | -40.74% | -59.30% | -59.30% | -28.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.99% | 48.99% | 79.08% | 79.08% | 35.41% |
| Change in Net Operating Assets | -911.34% | -911.34% | 71.17% | 71.17% | -69.73% |
| Cash from Operations | -22.85% | -22.85% | 55.45% | 55.45% | 25.35% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | 95.75% |
| Sale of Property, Plant, and Equipment | -68.14% | -68.14% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -2,777.66% |
| Other Investing Activities | 26.28% | 26.28% | -5.37% | -5.37% | 4,033.35% |
| Cash from Investing | 36.02% | 36.02% | -4.54% | -4.54% | 2,625.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 6.58% | 6.58% | 29.45% | 29.45% | 1.67% |
| Issuance of Common Stock | -6.87% | -6.87% | -40.92% | -40.92% | 13,628.57% |
| Repurchase of Common Stock | -1,363.00% | -1,363.00% | 44.32% | 44.32% | -70.52% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -31.88% | -31.88% | 100.00% | 100.00% | 2,499,500.00% |
| Cash from Financing | -142.55% | -142.55% | 43.07% | 43.07% | 1,722.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.49% | -41.49% | 26.20% | 26.20% | 301.06% |